Relative Bioavailability Study to Compare Inhalation of Terbutaline Sulphate 1,5mg Via Turbuhaler M3 With Turbuhaler M2

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

terbutaline sulphate delivered dose

0.4 mg terbutaline sulphate (delivered dose) per inhalation

DRUG

terbutaline sulphate metered dose

0.5 mg terbutaline sulphate (metered dose) per inhalation

Trial Locations (1)

Research Site, London